OG-L002

Overview

OG-L002 is a potent and highly selective LSD1 inhibitor with an IC 50 of 0.02 μM. OG-L002 is a potent monoamine oxidases (MAO) inhibitor with IC 50 s of 1.38 μM and 0.72 μM for MAO-A and MAO-B , respectively. OG-L002 potently inhibits the expression of HSV IE genes.

Application

Products | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Viral Infection | Products > Disease Areas > Depression | Products > Disease Areas > Parkinson's Disease | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Histone Demethylase | Products > Signaling Pathways > Monoamine Oxidase | Products > Signaling Pathways > HSV

Product Information

• Catalog No.: HY-19333
• CAS No.: 1357302-64-7
• Molecular Formula: C15H15NO
• Molecular Weight: 225.29
• Purity: 99.55%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 1.67 mg/mL (7.41 mM); Clear solution
• Availability: In-stock

Source

Original product source